Verve Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $873k | 66k | 13.28 |
| 2023-12-31 | $876k | 63k | 13.94 |
| 2023-09-30 | $659k | 50k | 13.26 |
| 2023-06-30 | $1.0M | 54k | 18.75 |
| 2023-03-31 | $556k | 39k | 14.42 |
| 2022-12-31 | $710k | 37k | 19.35 |
| 2022-09-30 | $982k | 29k | 34.30 |
| 2022-06-30 | $190k | 13k | 15.19 |
| 2022-03-31 | $279k | 12k | 22.99 |
| 2021-12-31 | $404k | 11k | 37.14 |